Infectious Diseases in the Immunocompromised Host
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.
TrialPACE™ – Medpace’s Patient Reported Outcome/eDiary Technology – Now Available on iOS and Android Devices
Free to download, TrialPACE™ is specifically designed to keep patients engaged in the clinical trials they are enrolled in.
Medpace to Present at the 3rd European QA Conference in Dublin
The 3rd European QA Conference is set to return November 6-8 this year to Dublin, one of Europe’s most popular destinations. Medpace will be participating…
The Biotech Industry and Medpace
Labiotech, a leading digital media company covering the European Biotech industry, recently featured Medpace in a white paper titled, “A Toolkit for Emerging Biotechs: Practical…
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
Speaking on Quality: Hear from Medpace Experts at the Upcoming Society of Quality Assurance (SQA) Annual Meeting
Medpace will once again be active participants in the Society of Quality Assurance’s (SQA) Annual Meeting and Quality College in Atlanta, GA. Our experts will…
Seamlessly Executing the Complexities of Clinical Packaging & Supplies
Medpace has a dedicated Clinical Packaging and Supplies (CP&S) department to assist Sponsors with the complexities of providing timely and compliant product throughout clinical studies.…
Medpace Strengthens Relationships with Key European Sites
To build a strong network of reliable, key sites Medpace established the Flagship site program consisting of the best-performing sites dedicated to best practices, expedited…
Medpace Expansion Initiatives Across Europe
While the CRO industry has grown primarily through mergers and acquisitions, Medpace has expanded through disciplined organic growth – expanding globally to operations in 36…
Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs
Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development